Evaluate Acquires Bioscience Advisors (Biosci)

Excelra Acquires BISC Global

April 19, 2023

Biotechnology

Excelra has acquired BISC Global, a consulting-led bioinformatics and data analytics services firm with offices in Europe and the US. The deal expands Excelra's AI/ML, bioinformatics and next-generation sequencing capabilities and combines complementary platforms and service offerings to accelerate drug discovery and development.

Discovery Life Sciences Acquires East West Biopharma

November 9, 2020

Healthcare Services

Discovery Life Sciences acquired East West Biopharma, a European human biospecimen contract research organization with a large biocollection network in Ukraine. The deal expands Discovery’s biospecimen collection and clinical site footprint across Europe, strengthening its global position as a leading provider of biospecimen and related scientific services.

Sia Partners Acquires Latham BioPharm Group

November 3, 2022

Consulting

Sia Partners has acquired Latham BioPharm Group (LBG), a U.S.-based life sciences consulting firm of nearly 60 consultants with roughly $20m in revenue, to launch a dedicated global Life Science Consulting division. The deal expands Sia Partners' capabilities in non-dilutive funding, product development, regulatory and clinical support, and strengthens its U.S. business and global life sciences offering.

Eurofins Discovery Acquires DiscoveryBioMed

July 5, 2022

Biotechnology

Eurofins Discovery has acquired DiscoveryBioMed, a Birmingham, Alabama–based contract research organization specializing in human primary- and immortalized-cell based bioassays. The acquisition strengthens Eurofins Discovery’s translational biology and human cell assay capabilities to expand its drug discovery services portfolio.

CellBio Scientific Acquires BioChain

May 1, 2025

Biotechnology

CellBio Scientific, a provider of life science tools and research services, has acquired BioChain, a biospecimen collection, preparation, and analysis company based in Newark, California. The acquisition expands CellBio Scientific's capabilities in spatial genomics and biospecimen workflows, consolidating BioChain with System Biosciences and Acepix Biosciences to create a broader translational research platform.

Discovery Life Sciences Acquires ReachBio Research Labs

April 11, 2023

Biotechnology

Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.